PM360

APRIL 22, 2024

Only they can share certain types of information with a growing number of medical stakeholders and back medical insights to guide strategic development and brand decisions. The race is on to develop the right key performance indicators, measurement tools, and processes for gauging the impact of MSL teams, ultimately to improve outcomes.

Education 52

Education Customer Relationship Management Medical science Medical 52

Pharmaceutical Technology

MAY 24, 2023

Forge Biologics has joined the public-private collaboration, the Bespoke Gene Therapy Consortium (BGTC), to expedite the development and manufacture of new AAV [adeno-associated virus] gene therapies to treat patients with rare diseases. Topic sponsors are not involved in the creation of editorial content.

Food and Drug Administration 96

Food and Drug Administration Manufacturing FDA Food 96

Pharma Leaders

APRIL 25, 2023

The FDA’s Fast Track process facilitates the development and expedites the review of drugs to treat serious conditions and fill unmet medical needs. Related Topics 117Lu-PNT2002 is currently under a phase 3 clinical trial setting, with enrollment complete and top-line data expected in the second half of this year.

Biopharma 52

Biopharma FDA Medical 52

Pharmaceutical Technology

DECEMBER 23, 2022

Eli Lilly and Company has expanded a licencing and partnership agreement with ProQR Therapeutics to discover, develop and market new genetic medicines. Topic sponsors are not involved in the creation of editorial content. Optimise your cell therapy process: a guide to cell thawing. Free Whitepaper.

Medicine 131

Medicine Pharmaceutical Marketing Sales 131

Clarivate

APRIL 21, 2022

In recent years, Ukraine has developed a reputation as an international information technology (IT) hub. Figure 1: Macro level topics 2017-2021 publications. Figure 2: Meso level topics 2017-2021 publications. Chemistry and engineering-related topics include graphene, phosphors and more (see Figure 3). Source: InCites.

Engineering 98

Engineering Education Electronics Medicine 98

Pharmaceutical Technology

JUNE 19, 2023

The pharma company will in-license a small number of gene therapy products and offer research grants to advance them through pre-clinical development. Topic sponsors are not involved in the creation of editorial content. Laurus Labs will be responsible for launching these products in India and emerging markets.

Pharmaceutical 98

Pharmaceutical Marketing Pharma Leads 98

Pharmaceutical Technology

DECEMBER 21, 2022

Moderna and the UK government have entered a ten-year strategic collaboration to build a messenger ribonucleic acid (mRNA) research, development and manufacturing facility in the country. The latest development comes after the parties announced an agreement in principle in June this year. Free Whitepaper.

Government 140

Government Manufacturing Pharmaceutical Marketing 140

Pharmaceutical Technology

JUNE 1, 2023

A new intracellular drug delivery centre will be established in the UK to support potential ribonucleic acid (RNA) vaccines and therapeutics , as well as the development of innovative drug delivery technologies. It will focus on studying and developing new lipid nanoparticle (LNP) formulations for the delivery of RNA medicine.

Medicine 97

Medicine Side effects Manufacturing Leads 97

Pharmaceutical Technology

APRIL 14, 2023

Twist Bioscience has introduced Twist T-cell receptor (TCR) and Twist chimeric antigen receptor (CAR) libraries to facilitate the development of cell therapies. Researchers will now be able to speed up the creation of tailor-made libraries that can help in identifying and developing new cell therapies.

Leads 98

Leads Pharmaceutical Patients 98

Pharmaceutical Technology

MAY 23, 2023

Avrobio will retain complete rights to its HSC gene therapies portfolio developed to treat Pompe disease, Gaucher disease type 1 and type 3, and Hunter syndrome. Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Food and Drug Administration 103

Food and Drug Administration Food Leads Pharmaceutical 103

Pharmaceutical Technology

AUGUST 2, 2022

GreenLight’s process from formulation of the drug substance and lipid nanoparticle to bulk drug product can be carried out in this facility. An effective scale-up and fit of GreenLight’s process to Samsung Biologics’ Songdo plant were shown in all comparability data validating with anticipated outcomes.

Engineering 104

Engineering Manufacturing Pharmaceutical 104

Pharmaceutical Technology

MARCH 28, 2023

Vertex Pharmaceuticals has signed a new non-exclusive licensing agreement with CRISPR Therapeutics to expedite the development of its hypoimmune cell therapies to treat type 1 diabetes (T1D). It edits genes by precisely cutting DNA, then allowing natural DNA repair processes to take over.

Pharmaceutical 94

Pharmaceutical Leads Marketing Patients 94

European Pharmaceutical Review

AUGUST 3, 2022

The newly created Working Party’s first task will be to develop a consolidated strategy for future standards addressing these vaccines and their components. Information on this process can be found here. Ghana and Nigeria’s regulatory authorities have already achieved ML3 status.

Manufacturing 97

Manufacturing Government Safety Medicine 97

Pharmaceutical Technology

FEBRUARY 16, 2023

The University of Texas MD Anderson Cancer Center has entered a strategic collaboration with biotech company Xilis for advancing new technology and expediting new cancer therapy development. Under the deal, MD Anderson and Xilis aim to advance the development of drug and discovery projects using the MOS technology.

Pharmaceutical 96

Pharmaceutical Patients Medicine Leads 96

Pharmaceutical Technology

MAY 30, 2023

As part of an exclusive licensing agreement, Amplo Biotechnology secured access to AAV-ColQ data developed by Professor Kinji Ohno’s laboratory at Nagoya University, which forms the basis of the therapy. It also develops adeno-associate virus-based gene therapies for neuromuscular junction disorders.

Safety 97

Safety Patients Leads Pharmaceutical 97

Pharmaceutical Technology

APRIL 3, 2023

The development pipeline of such therapies has been growing strongly and more and more are reaching major milestones,” said René Fáber, member of the executive board and head of the bioprocess solutions division of Sartorius, in a statement. Topic sponsors are not involved in the creation of editorial content.

Media 98

Media Pharmaceutical Marketing Manufacturing 98

Pharmaceutical Technology

JANUARY 17, 2023

Spain’s Hospital Universitario 12 de Octubre researchers, along with the Josep Carreras Leukaemia Research Institute, have developed a new cell therapy based on STAb cells to treat a type of leukaemia. The Spanish Association Against Cancer (AECC) provided funding for the new STAb therapy development. Free Whitepaper.

Specialization 110

Specialization Patients Pharmaceutical Leads 110

Pharmaceutical Technology

MARCH 8, 2023

The multi-year collaboration aims to develop new technologies which will help in improving clinical outcomes for patients. The programme aims to develop advanced technologies and applications to improve human health. Topic sponsors are not involved in the creation of editorial content.

Food and Drug Administration 97

Food and Drug Administration Manufacturing Engineering Food 97

Pharmaceutical Technology

MAY 19, 2023

Myeloid Therapeutics has raised $73m to support the continued clinical development of its lead cell therapy programme, MT-101, in Phase I/II trials for T cell lymphoma. The financing will help to fast-track the development of other in vivo programming candidates into clinical trials.

Leads 98

Leads Patients Pharmaceutical 98

Pharmaceutical Technology

MARCH 29, 2023

Regeneron Pharmaceuticals has collaborated with Sonoma Biotherapeutics to discover, develop and commercialise new regulatory T cell (Treg) therapies for autoimmune diseases. The two companies will together research and develop T cell therapies for Crohn’s disease and ulcerative colitis, as well as two other undisclosed indications.

Leads 98

Leads Engineering Pharmaceutical Patients 98

Pharmaceutical Technology

MARCH 20, 2023

RVAC Medicines has announced a research collaboration with the University of Pennsylvania (Penn) for the discovery and development of mRNA vaccines. The partnership will focus on developing potential new vaccines to treat certain selected autoimmune indications, as well as food allergies.

Medicine 98

Medicine Food Leads Patients 98

Pharmaceutical Technology

APRIL 12, 2023

Clinical-stage biotechnology firm LyGenesis has formed a joint research collaboration with Imagine Pharma to develop new cell therapies for type 1 diabetes (T1D). Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Pharma 98

Pharma Leads Patients Pharmaceutical 98

Pharmaceutical Technology

NOVEMBER 16, 2022

Under the deal, the LentiPeak lentiviral vector technology platform and cell therapy production expertise of ElevateBio BaseCamp will be used by Affini-T to develop its investigational oncogenic driver programmes in the clinic. Topic sponsors are not involved in the creation of editorial content.

Engineering 98

Engineering Manufacturing Pharmaceutical Patients 98

Clarivate

SEPTEMBER 19, 2023

In addition to the number of citations, our selection process considers whether the authors of the highly cited papers were the primary discoverers or individuals who extended the work of pioneers – it is the pioneers that have priority in the Nobel Assembly’s choices. For Economics, the threshold is around 1,000 citations.

Electronics 111

Electronics Medicine Government Patients 111

Pharmaceutical Technology

JANUARY 5, 2023

Capsida Biotherapeutics and Eli Lilly and Company ’s wholly owned subsidiary Prevail Therapeutics have announced a partnership for the development of non-invasive gene therapies for central nervous system (CNS) diseases. Topic sponsors are not involved in the creation of editorial content.

Engineering 95

Engineering Leads Pharmaceutical Marketing 95

Pharmaceutical Technology

APRIL 20, 2023

Targovax has unveiled plans to rebrand as Circio , reflecting its strategic shift to focus on expediting the development of its innovative circular RNA (circRNA) platform. Circio aims to develop new circRNA medicines initially for cancer, then plans to expand rapidly into vaccines and gene therapy.

Engineering 96

Engineering Leads Medicine Pharmaceutical 96

Pharmaceutical Technology

FEBRUARY 9, 2023

The collaboration is aimed at discovering and developing new advanced treatments for genitourinary (GU) tumours as well as other related serious diseases using ReviR’s RNA-targeted technologies. Its initial focus is to develop therapeutics in oncology, CNS, and genetically defined disease indications.

Biopharma 96

Biopharma Pharmaceutical Patients Marketing 96

Pharmaceutical Technology

DECEMBER 8, 2022

Under the prior deal, Daiichi Sankyo acquired exclusive rights for the development, manufacturing and commercialisation of Yescarta in Japan. Topic sponsors are not involved in the creation of editorial content. Optimise your cell therapy process: a guide to cell thawing. Free Whitepaper.

Manufacturing 122

Manufacturing Marketing Engineering Patients 122

Pharmaceutical Technology

DECEMBER 5, 2022

The hub will connect Queensland scientists with the teams at Sanofi’s mRNA Centre of Excellence in the US and France, putting them at the front of international vaccine development and biomedical research. In October, Sanofi and BioMed X signed a research partnership to utilise artificial intelligence (AI) for developing drugs.

Government 98

Government Pharmaceutical Marketing Leads 98

Pharmaceutical Technology

NOVEMBER 29, 2022

Neogene focuses on discovering, developing and producing next-generation T-cell receptor therapies (TCR-Ts) that provide a new cell therapy approach for fighting cancer. Topic sponsors are not involved in the creation of editorial content. Optimise your cell therapy process: a guide to cell thawing.

Manufacturing 111

Manufacturing Leads Patients Pharmaceutical 111

Pharmaceutical Technology

APRIL 14, 2023

The company and the researchers, with Professor Krishanu Saha as principal investigator (PI) and Dr Christian Capitini as co-PI, will develop a GD2 CAR T-cell therapeutic candidate to treat neuroblastoma, a cancer type that generally affects young children. Topic sponsors are not involved in the creation of editorial content.

Engineering 105

Engineering Patients Leads Pharmaceutical 105

Pharmaceutical Technology

MAY 22, 2023

Vyjuvek is a non-invasive, topical, re-dosable gene therapy that delivers functional human COL7A1 gene copies to offer wound healing. In the GEM-1/2 trial, repeat topical applications of Vyjuvek resulted in full-length cutaneous COL7 expression, durable wound closure and anchoring fibril assembly with minimal adverse events.

FDA 52

FDA Food and Drug Administration Patients Food 52

Pharmaceutical Technology

AUGUST 17, 2022

Biopharmaceutical contract development and manufacturing organisation (CDMO) AGC Biologics has entered a strategic collaboration with RoosterBio to expedite the manufacturing of cell and exosome therapies. It will also have the potential to scale to Phase III clinical development and commercial manufacturing.

Manufacturing 52

Manufacturing Networking Media Engineering 52

Pharmaceutical Technology

DECEMBER 12, 2022

Gilead company Kite has entered an international strategic partnership with Arcellx for the joint development and commercialisation of the latter’s T-cell therapy, CART-ddBCMA, to treat relapsed or refractory multiple myeloma patients. Topic sponsors are not involved in the creation of editorial content. Free Whitepaper.

Manufacturing 105

Manufacturing Marketing Pharmaceutical Patients 105

European Pharmaceutical Review

OCTOBER 5, 2023

What are the key topics you plan to cover during your session at CPHI Barcelona? I firmly believe that manufacturing plays a pivotal role in this endeavour, and I will delve into topics such as production system optimisation and the standardisation of chemistry, manufacturing, and control (CMC) processes.”

Manufacturing 90

Manufacturing Consulting Patients Marketing 90

Pharmaceutical Technology

MARCH 10, 2023

On 10 March, the National Health Service Blood and Transplant (NHSBT) opened a new Clinical Biotechnology Centre (CBC) with the aim of improving the UK’s ability to develop and manufacture cell and gene therapies. Personalised medicines will also be developed at the centre.

Manufacturing 105

Manufacturing Distribution Medicine Patients 105

Pharmaceutical Technology

MARCH 31, 2023

Recently, Moderna entered into a strategic collaboration with Generation Bio for non-viral genetic medicines development. Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Manufacturing 105

Manufacturing Government Medicine Healthcare 105